Workflow
Electrochem Solutions, Inc.
icon
Search documents
Ultralife Corporation Reports Second Quarter Results
Globenewswire· 2025-08-07 11:00
Core Viewpoint - Ultralife Corporation faced challenges in the second quarter of 2025, with flat organic sales in Battery & Energy Products and a significant decline in Communications Systems sales, but anticipates improved results in the second half of the year and into 2026 due to various factors including new product programs and increased demand from key sectors [1][2]. Financial Performance - Revenue for the second quarter was $48.6 million, a 13.0% increase from $43.0 million in the same quarter of 2024 [3][6]. - Battery & Energy Products sales rose by 25.0% to $45.9 million, largely due to the inclusion of Electrochem Solutions, Inc. [3][6]. - Excluding Electrochem, Battery & Energy Products sales were flat year-over-year, with government/defense sales up 61.1% but commercial sales down 20.4% [3][6]. - Communications Systems sales decreased by 57.2% to $2.7 million, primarily due to shipment delays and order timing issues [3][6]. Profitability Metrics - Gross profit was $11.6 million, representing 23.9% of revenue, down from 26.9% in the same quarter last year [4][6]. - Operating income was $2.3 million, a decline from $3.9 million in the prior year, with an operating margin of 4.6% compared to 9.1% [7][6]. - Net income attributable to Ultralife was $0.9 million, or $0.05 per diluted share, down from $3.0 million or $0.18 per diluted share in the second quarter of 2024 [9][6]. Operating Expenses - Operating expenses increased to $9.3 million from $7.6 million in the same quarter last year, reflecting higher costs associated with new product development and the inclusion of Electrochem [5][6]. - Operating expenses accounted for 19.2% of revenue, compared to 17.8% in the previous year [5][6]. Future Outlook - The company expects a rebound in its Communications Systems business and early purchase orders from new product programs in the battery segment, alongside growth in defense spending and opportunities in the oil & gas sector [2][1]. - Priorities include converting long-term product development into revenue and enhancing operational efficiency for sustainable growth [2][1].
Ultralife Corporation Reports Fourth Quarter Results
Newsfilter· 2025-04-01 11:00
Core Insights - Ultralife Corporation has completed the acquisition of Electrochem and has begun the integration process to realize the benefits of this investment [3][4] - The company reported a revenue of $43.9 million for Q4 2024, slightly down from $44.5 million in Q4 2023, with Electrochem contributing $6.1 million to this figure [5][6] - The company is optimistic about its future growth, citing a healthy backlog of $102.2 million and plans for new product launches in high-growth markets [4][5] Financial Performance - Q4 2024 revenue was $43.9 million, including $6.1 million from Electrochem, compared to $44.5 million in Q4 2023 [5][6] - Battery & Energy Products sales increased by 11.7% to $39.9 million, while Communications Systems sales decreased by 55.1% to $4.0 million [5][6] - Gross profit for Q4 2024 was $10.6 million, or 24.2% of revenue, down from $11.4 million, or 25.6% of revenue, in Q4 2023 [6][7] Operating Metrics - Operating income for Q4 2024 was $1.5 million, down from $3.6 million in Q4 2023, impacted by one-time acquisition costs and a decline in Communications Systems sales [6][9] - Operating expenses increased to $9.1 million in Q4 2024 from $7.8 million in Q4 2023, reflecting costs associated with the acquisition of Electrochem [8][9] - The company reported a GAAP EPS of $0.01 for Q4 2024, compared to $0.17 for Q4 2023 [10][21] Yearly Overview - For the fiscal year 2024, total revenue was $164.5 million, a 3.7% increase year-over-year, remaining flat when excluding Electrochem [6][20] - Operating income for the year was $10.0 million, compared to $9.5 million in 2023, despite one-time costs related to the acquisition [6][20] - The company achieved an adjusted EBITDA of $16.5 million for the year, up from $15.7 million in 2023 [6][11] Strategic Outlook - The company is focused on completing the integration of Electrochem to achieve manufacturing cost efficiencies and vertical integration savings [4][5] - Ultralife aims to leverage its strengthened sales and marketing leadership to expedite organic growth and enhance its global brand [4][5] - The company is confident in its ability to deliver profitable growth and incremental cash flow, which will support debt reduction and strategic capital expenditures [4][5]